Literature DB >> 18369734

Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplant.

Mohammad S Khan1, Sami Ahmed, Ben Challacombe, David Goldsmith, Michael Steward.   

Abstract

We report a case of post-transplantation lymphoproliferative disorder presenting as a symptomatic lymphocele 12 years after cadaveric renal transplantation for IgA nephropathy. The presentation, imaging, and management are discussed. We review current literature concerning PTLD, posttransplantation lymphoceles, and state-of-the-art imaging techniques.

Entities:  

Mesh：

Year:  2008        PMID： 18369734     DOI： 10.1007/s11255-008-9367-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  9 in total

1.  Diagnostics and therapy of lymphoceles after kidney transplantation.

Authors:  A Hamza; K Fischer; E Koch; A Wicht; M Zacharias; H Loertzer; P Fornara
Journal:  Transplant Proc       Date:  2006-04       Impact factor: 1.066

2.  Long-term outcome of cadaveric renal transplant after treatment of symptomatic lymphocele.

Authors:  G P Smyth; G Beitz; M P Eng; N Gibbons; D P Hickey; D M Little
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

3.  Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients.

Authors:  P J Pickhardt; M J Siegel
Journal:  Radiology       Date:  1999-10       Impact factor: 11.105

4.  Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.

Authors:  M F Mamzer-Bruneel; C Lomé; E Morelon; V Levy; P Bourquelot; F Jacobs; A Gessain; E Mac Intyre; N Brousse; H Kreis; O Hermine
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

5.  Complex posttransplantation abnormalities of renal allografts: evaluation with MR imaging.

Authors:  M G Ali; F V Coakley; H Hricak; P N Bretan
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

6.  Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation.

Authors:  C E Kew; R Lopez-Ben; J K Smith; M L Robbin; W J Cook; R S Gaston; M H Deierhoi; B A Julian
Journal:  Transplantation       Date:  2000-03-15       Impact factor: 4.939

7.  Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy.

Authors:  P K Li; K Tsang; C C Szeto; T Y Wong; K F To; C B Leung; S F Lui; S Yu; F M Lai
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

8.  Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.

Authors:  S A Birkeland; S Hamilton-Dutoit; K Bendtzen
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

9.  Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.

Authors:  Margaret L Gulley; Lode J Swinnen; Kerry T Plaisance; Carrie Schnell; Thomas M Grogan; Barbara G Schneider
Journal:  Transplantation       Date:  2003-09-27       Impact factor: 4.939
  9 in total
  1 in total

Review 1.  Hematologic abnormalities following renal transplantation.

Authors:  Mark A Marinella
Journal:  Int Urol Nephrol       Date:  2009-03-20       Impact factor: 2.266
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.